CLINICAL FEATURES AND LABORATORY CHARACTERISTICS OF PATIENTS WITH CANNABIS AND SYTHENTIC CANNABIS POISONINGS

Bùi Công Thép1,, Đặng Thị Xuân2, Hà Trần Hưng1,2
1 Hanoi Medical University
2 Poison Control Center, Bach Mai Hospital

Main Article Content

Abstract

Objectives: to describe the clinical and laboratory characteristics of patient with acute poisoning of cannabis (THC) and some synthetic cannabidiol (SC) at Vietnam Poison Control Center, Bach Mai Hospital. Methods: prospective descriptive study on 48 patients diagnosed with acute cannabis (THC) and some synthetic cannabidiol (SC) poisoning treated at the Poison Control Center from January 2020 to October 2021. Results: Among the study patients, there were 39 male patients (81.3%), the average age of the study group was 28.1 ± 11.5 (13 - 61) years old. The onset symptoms of poisoning developed 9 ± 6.6 minutes after use. Abuse agents were mainly in the form of plant fibers 54.2%, therefore smoking accounted for 87.5%, under the tongue 8.3%, eating (4.2%), throat spray (2.1%). Neurotoxic and psychotic symptoms appeared soon after poisoning were dizziness, ataxia or reduced ability to coordinate (64.6%), agitation 47.9%, visual hallucinations (45.8%), decreased consciousness, syncope (33.3%), convulsions (20.8%), delusions of harm (16.7%), dyspnea (35.4%). The laboratory features included metabolic acidosis (12.8%), acute rhabdomyolysis (10.4%), hypokalemia (47.9%). The most common arrhythmias were sinus tachycardia (35.4%), sinus bradycardia (2.1%) and sinus arrhythmia 1 patient (2.1%). The group of patients with synthetic cannabis poisoning tended to had more seveve symptoms than the THC group. Conclusion: The study revealed the clinical and laboratory characteristics of patients with cannabis, synthetic cannabis poisoning, that was necessary for early management and prognosis of complications.

Article Details

References

1. WHO Cannabis. WHO. https:// www.who.int/substance_abuse/facts/cannabis/en/. Accessed May 5, 2020.
2. Sharma P, Murthy P, Bharath MMS. Chemistry, Metabolism, and Toxicology of Cannabis: Clinical Implications. Iran J Psychiatry. 2012;7(4):149-156.
3. Tournebize J, Gibaja V, Kahn JP. Acute effects of synthetic cannabinoids: Update 2015. Subst Abuse. 2017;38(3):344-366. doi:10.1080/ 08897077.2016.1219438
4. Noble MJ, Hedberg K, Hendrickson RG. Acute cannabis toxicity. Clin Toxicol. 2019;57(8):735-742. doi:10.1080/15563650.2018.1548708
5. Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012;60(4):435-438. doi:10.1016/ j.annemergmed.2012.03.007.